These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15459901)

  • 21. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
    J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.
    Ren G; Esser S; Jochum C; Schlaak JF; Gerken G; Schadendorf D; Dittmer U; Wu G; Yuan Z; Timm J
    AIDS; 2012 Nov; 26(17):2145-53. PubMed ID: 22948268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
    Lee CK; Han KH; Suh JH; Cho YS; Won SY; Chon CY; Moon YM; Park IS
    Korean J Hepatol; 2005 Mar; 11(1):34-42. PubMed ID: 15788883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.
    Turk G; Gherardi MM; Laufer N; Saracco M; Luzzi R; Cox JH; Cahn P; Salomon H
    J Virol; 2008 Mar; 82(6):2853-66. PubMed ID: 18184702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ; He HX; Zhuang H
    J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.
    Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on interferon-gamma (IFN-gamma) response by T cells stimulated by hepatitis B virus core antigen.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Apr; 30(1):9-15. PubMed ID: 15376464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood amounts and suppressive in vitro activity of CD8+11b(+)-lymphocytes from HIV-infected children, related to hepatitis B or C virus association.
    Voiculescu C; Avramescu C; Radu E; Bălăşoiu M; Turculeanu A
    Rom J Virol; 1995; 46(3-4):171-8. PubMed ID: 9179968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of CD8+ T-cell response in HIV infection.
    Benito JM; López M; Soriano V
    AIDS Rev; 2004; 6(2):79-88. PubMed ID: 15332430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B virus reactivation in patients infected with HIV].
    Ciutică I; Bastides F; Besnier M; Barin F; Choutet P
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):59-63. PubMed ID: 9235146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen.
    Gandhi RT; Wurcel A; McGovern B; Lee H; Shopis J; Corcoran CP; Toner S; Giachetti C; Dockter J; Sax PE; Ukomadu C
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):439-41. PubMed ID: 14615664
    [No Abstract]   [Full Text] [Related]  

  • 40. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.
    Jung MC; Hartmann B; Gerlach JT; Diepolder H; Gruber R; Schraut W; Grüner N; Zachoval R; Hoffmann R; Santantonio T; Wächtler M; Pape GR
    Virology; 1999 Sep; 261(2):165-72. PubMed ID: 10497102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.